Intelligent Bio Solutions Inc. (INBS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Intelligent Bio Solutions Inc. (INBS) has a cash flow conversion efficiency ratio of -0.831x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.85 Million) by net assets ($3.43 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See INBS cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Intelligent Bio Solutions Inc. - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how Intelligent Bio Solutions Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Intelligent Bio Solutions Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Intelligent Bio Solutions Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Charan Insurance Public Company Limited
BK:CHARAN
|
0.003x |
|
Iqstel Inc
NASDAQ:IQST
|
-0.012x |
|
Bullfrog AI Holdings, Inc. Common Stock
NASDAQ:BFRG
|
-0.570x |
|
ChargePanel AB
ST:CHARGE
|
-0.513x |
|
BIRKS GROUP INC. A
F:2BG
|
N/A |
|
Xylo Technologies Ltd.
NASDAQ:XYLO
|
-0.007x |
|
The Calmer Co International Ltd
AU:CCO
|
-6.608x |
|
Professional Diversity Network Inc
NASDAQ:IPDN
|
0.126x |
Annual Cash Flow Conversion Efficiency for Intelligent Bio Solutions Inc. (2017–2025)
The table below shows the annual cash flow conversion efficiency of Intelligent Bio Solutions Inc. from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Intelligent Bio Solutions Inc. worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | $2.81 Million | $-9.68 Million | -3.439x | -194.03% |
| 2024-06-30 | $8.18 Million | $-9.57 Million | -1.170x | +41.54% |
| 2023-06-30 | $3.69 Million | $-7.38 Million | -2.001x | -290.04% |
| 2022-06-30 | $6.55 Million | $-3.36 Million | -0.513x | +31.85% |
| 2021-06-30 | $15.01 Million | $-11.30 Million | -0.753x | -887.29% |
| 2020-06-30 | $-5.21 Million | $-498.62K | 0.096x | -93.18% |
| 2019-06-30 | $-3.98 Million | $-5.58 Million | 1.402x | -20.21% |
| 2018-06-30 | $-3.06 Million | $-5.38 Million | 1.758x | +4160.83% |
| 2017-06-30 | $-5.91 Million | $-243.89K | 0.041x | -- |
About Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The compan… Read more